Biotech-focused investor Cormorant Asset Management rebuilt its stake above 6% on Tuesday. ・Cormorant disclosed ownership of ...

Krystal Biotech Inc (NASDAQ:KRYS) on Tuesday delivered fourth-quarter results that came in ahead of Wall Street forecasts, ...

Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

Japan-based cell therapy company Innovacell is planning to end a drought of biotech IPOs on the Tokyo stock exchange next week, the business’ CEO has confirmed. | Japan-based cell therapy company ...

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

A group of European venture capital firms is banding together to try to improve the funding landscape for biotech startups.

Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.

From top left, clockwise: Fred Hutch’s Hilary Hehman; Oregon Venture Fund’s Eric Rosenfeld; Alexandria’s Alice Ly; University of Washington’s François Baneyx; sp3nw’s Michaele Armstrong; and ...